Stay updated on B-701 & Pembrolizumab in Urothelial Cancer Clinical Trial
Sign up to get notified when there's something new on the B-701 & Pembrolizumab in Urothelial Cancer Clinical Trial page.

Latest updates to the B-701 & Pembrolizumab in Urothelial Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe page's revision indicator was updated from v3.6.3 to v3.6.4, signaling a small frontend/metadata update to the study page. No study data or textual content appears to be altered.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedA new page revision (v3.6.3) was added to replace the previous revision (v3.6.2), indicating a minor update to the page's content or metadata.SummaryDifference0.0%

- Check39 days agoChange DetectedThe page now displays Revision: v3.6.2, replacing the previous v3.6.0, indicating a software/template update. There are no apparent changes to the study details or user-facing content.SummaryDifference0.0%

- Check53 days agoChange DetectedThe page now indicates recruitment is closed and adds new sections such as How to Read a Study Record, Common Questions, and How to Join a Study, along with a header rewording for Intervention/Treatment and the revision label Revision: v3.6.0.SummaryDifference0.4%

- Check61 days agoChange DetectedRevision label updated from v3.5.4 to v3.5.5, reflecting a new page release.SummaryDifference0.0%

- Check82 days agoChange DetectedThe page revision updated to version v3.5.4, replacing the previous v3.5.3; this indicates an administrative update to the page content.SummaryDifference0.0%

Stay in the know with updates to B-701 & Pembrolizumab in Urothelial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the B-701 & Pembrolizumab in Urothelial Cancer Clinical Trial page.